Physician profile
Floyd E Seskin
NPI 1104844059
$6,697.51
in general payments reported to CMS, 2019-2025
38 companies · $1,896 in 2025
The $1,896 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,455 · 2020: $354 · 2021: $438 · 2022: $380 · 2023: $1,735 · 2024: $439 · 2025: $1,896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,145 · Food and Beverage: $1,632 · Education: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,144.84 |
| Food and Beverage | $1,631.61 |
| Education | $293.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,537.70 | 2021-2025 | Urolift, Barrigel |
| Angiodynamics, INC. | $1,180.95 | 2023 | Nanoknife |
| Neotract INC. | $841.11 | 2019-2020 | |
| Astellas Pharma US INC | $713.06 | 2019-2023 | Myrbetriq, Xtandi |
| Abbvie INC. | $401.43 | 2019-2025 | Durysta, Botox |
| Procept Biorobotics Corporation | $334.00 | 2022-2025 | Aquabeam System |
| Coloplast Corp | $208.44 | 2019 | |
| Urovant Sciences INC | $102.82 | 2021-2022 | |
| Comsort, INC | $100.00 | 2019 | |
| Sumitomo Pharma America, INC. | $92.41 | 2023-2025 | Gemtesa |
| Tolmar, INC. | $90.63 | 2023-2025 | Jatenzo, Eligard |
| Tolmar Pharmaceuticals, INC. | $90.42 | 2020-2021 | |
| Blue Earth Diagnostics | $89.59 | 2019-2025 | Posluma |
| Olympus America INC. | $85.79 | 2020-2025 | Uropass |
| Axonics, INC. | $78.63 | 2021-2023 | Axonics |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $63.02 | 2019-2020 | |
| Valencia Technologies Corporation | $53.13 | 2025 | Ecoin Device Kit |
| Janssen Biotech, INC. | $51.97 | 2019-2021 | |
| Urogen Pharma, INC. | $51.22 | 2021-2025 | |
| Progenics Pharmaceuticals, INC. | $48.67 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $43.10 | 2020-2021 | |
| Bluewind Medical | $40.81 | 2025 | Revi |
| Boston Scientific Corporation | $35.00 | 2025 | Axonics |
| Acerus Pharmaceuticals Corporation | $32.62 | 2020-2022 | |
| Dendreon Pharmaceuticals LLC | $31.88 | 2025 | Provenge |
| Abc Home Medical Supply, INC. | $31.57 | 2022 | |
| Sun Pharmaceutical Industries INC. | $29.49 | 2024 | |
| Myovant Sciences INC. | $27.47 | 2021 | |
| Calyxo, INC. | $26.25 | 2025 | Cvac Aspiration System |
| Palette Life Sciences, INC. | $25.53 | 2022 | |
| Agiliti Surgical, INC. | $24.49 | 2019 | |
| Halozyme INC | $22.57 | 2023 | |
| Immunitybio, INC. | $21.71 | 2025 | |
| Antares Pharma, INC. | $21.69 | 2020 | |
| Ambu INC. | $20.89 | 2024 | |
| Amniox Medical, INC. | $19.97 | 2019 | |
| Verity Pharmaceuticals INC. | $15.22 | 2025 | Trelstar |
| Kerecis Limited | $12.26 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Floyd Seskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.